Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars PartnershipBusiness Wire • 07/24/23
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech SA - ALVOPRNewsWire • 07/17/23
INVESTIGATION ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Alvotech and Encourages Investors with Losses to Contact the FirmAccesswire • 07/12/23
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Alvotech and Encourages Investors with Losses to Contact the FirmAccesswire • 07/08/23
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Alvotech and Encourages Investors with Losses In Excess of $100,000 to Contact the FirmAccesswire • 07/07/23
Alvotech Provides Regulatory Update on Second Biologics License Application for AVT02GlobeNewsWire • 06/28/23
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Alvotech and Encourages Investors with Losses to Contact the FirmAccesswire • 06/20/23
ALVO, ALVOW INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO, ALVOWPRNewsWire • 06/14/23
Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®Business Wire • 06/12/23
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Alvotech and Encourages Investors with Losses In Excess of $100,000 to Contact the FirmAccesswire • 06/02/23
INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Alvotech and Encourages Investors with Losses to Contact the FirmAccesswire • 05/29/23
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVOWPRNewsWire • 05/26/23
Alvotech and Advanz Pharma extend strategic partnership to commercialize five proposed biosimilars in EuropeGlobeNewsWire • 05/24/23
Alvotech Reports Financial Results for First three Months of 2023 and Provides Business UpdateGlobeNewsWire • 05/19/23
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVOPRNewsWire • 05/11/23
Alvotech enters into commercialization agreement with Polifarma for proposed biosimilar to Eylea® (aflibercept)GlobeNewsWire • 05/10/23
Fuji Pharma: High Scope For Growth In U.S. Foray, Biosimilars, And Women's Health DrugsSeeking Alpha • 05/08/23
Alvotech Initiates Confirmatory Patient Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®GlobeNewsWire • 05/04/23